Ruth O’Regan
University of Rochester(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Estrogen and related hormone effects, HER2/EGFR in Cancer Research
Most-Cited Works
- → Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA(2008)396 cited
- → Quantum Dots for Human Mesenchymal Stem Cells Labeling. A Size-Dependent Autophagy Activation(2006)243 cited
- → Everolimus: side effect profile and management of toxicities in breast cancer(2013)97 cited
- → A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial.(2022)73 cited
- → New targeted therapies in breast cancer(2004)48 cited
- → Inorganic Nanoparticles for Predictive Oncology of Breast Cancer(2008)45 cited
- → Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis(2013)40 cited
- → Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer(2024)34 cited
- → Primary multifocal skeletal Hodgkin’s disease confined to bone(1995)23 cited
- → Social media and clinical trials: The pros and cons gain context when the patient is at the center(2018)22 cited